Direxion Daily S&P Biotech Bull 3X Shares
LABU
LABU
36 hedge funds and large institutions have $56.8M invested in Direxion Daily S&P Biotech Bull 3X Shares in 2024 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+3
Holders Change %
+9.09%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
10
Reduced
10
Closed
7
Calls
$85.3M
Puts
$54M
Net Calls
+$31.3M
Net Calls Change
-$7.27M
Top Buyers
| 1 |
HF
1
HRT Financial
New York
|
$7.23M |
| 2 |
2
Goldman Sachs
New York
|
$5.68M |
| 3 |
3
Bank of America
Charlotte,
North Carolina
|
$6.76M |
| 4 |
GS
4
GTS Securities
New York
|
$4.61M |
| 5 |
5
Simplex Trading
Chicago,
Illinois
|
$2.57M |
Top Sellers
| 1 |
1
Barclays
London,
United Kingdom
|
$0 |
| 2 |
2
JPMorgan Chase & Co
New York
|
$240K |
| 3 |
3
Group One Trading
Chicago,
Illinois
|
$0 |
| 4 |
4
Morgan Stanley
New York
|
$3.15M |
| 5 |
5
Citadel Advisors
Miami,
Florida
|
$6.64M |
